ADMA Biologics

ADMA · NASDAQ

$11.23+$0.16 (+1.45%)TodayMarket closed ·
Prev close $11.07

Who owns ADMA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 49.3% of ADMA’s shares.

  • BlackRock Institutional Trust Company, N.A.14.7%
  • State Street Investment Management (US)7.4%
  • Vanguard Capital Management, LLC4.4%
  • Vanguard Portfolio Management, LLC4.4%
  • Next 6 largest institutions18.5%
  • All other shareholders50.7%
Top institutional holders of ADMA
HolderShares% of shares
BlackRock Institutional Trust Company, N.A.34.00M14.67%
State Street Investment Management (US)17.12M7.38%
Vanguard Capital Management, LLC10.10M4.36%
Vanguard Portfolio Management, LLC10.09M4.35%
Rubric Capital Management LP9.34M4.03%
Capital Research Global Investors8.76M3.78%
First Trust Advisors L.P.7.80M3.36%
Geode Capital Management, L.L.C.6.06M2.61%
Caligan Partners, LP5.73M2.47%
D. E. Shaw & Co., L.P.5.27M2.28%

Largest mutual fund holders

Top mutual fund holders of ADMA
HolderShares% of shares
iShares Core S&P Small-Cap ETF14.13M6.10%
First Trust NYSE Arca Biotechnology Index Fund9.97M4.30%
American Funds SMALLCAP World Fund8.52M3.68%
State Street SPDR S&P Biotech ETF8.20M3.54%
Vanguard Total Stock Market Index Fund7.05M3.04%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $250.87K (3 trades) of ADMA on the open market, with no sales.

Latest ADMA insider transactions
InsiderTypeSharesValue
Kestenberg-Messina Kaitlin M.Tax withholding3.18K$26.59K
Kohler TerryAward136.36K—
Kohler TerryAward85.13K—
Grossman Jerrold BBuy6.40K$50.62K
Grossman Jerrold BBuy12.50K$100.13K
Grossman Jerrold BBuy12.50K$100.13K

Short interest

Settled Sep 30, 2026

Shares short
20.60M
Days to cover
5.67
% of shares outstanding
8.89%
Average daily volume
3.63M
Change since last report
−14.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.